Improving the quality of life

for millions of patients

View latest announcements

Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development.

OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.

All News

  • 28 June 2018

    OXFORD CANNABINOID TECHNOLOGIES GOES GLOBAL AS IT ANNOUNCES CLOSE OF SERIES A FUNDRAISING ROUND AND MANAGEMENT TEAM LINE-UP

  • 01 June 2017

    Embracing the medical potential of cannabinoids

    SOURCE: THE MEDICINE MAKER

  • 01 June 2017

    Smashing the stigma with science

    SOURCE: THE MEDICINE MAKER